INTENDED USE
The SARS-CoV-2 Rapid Test is an in vitro immunochromatographic, one-step test. It is intended for the rapid qualitative detection of the SARS-CoV-2 virus antigen in nasal swabs (from the anterior nostrils) of people suspected of being infected with COVID-19 in the first seven days after the onset of symptoms. The SARS-CoV-2 rapid antigen test should not be used as the sole method to diagnose or rule out SARS-CoV-2 infection. Children under 14 years of age should perform the test with the help of adults.
SUMMARY
The new coronaviruses belong to the β-coronavirus. COVID-19 is an infectious acute respiratory disease. People are generally susceptible to it. Currently, the greatest source of infections is formed by patients infected with the new coronavirus, although asymptomatic patients may also be the source of the infection. Current epidemiological studies show that the incubation period is from 1 to 14 days, but most often from 3 to 7 days. The main symptoms are fever, fatigue, loss of sense of smell and taste, and a dry cough. In some cases, symptoms such as stuffy nose, runny nose, sore throat, muscle aches and diarrhea have also been observed.
Follow the instructions included in the package .
